Compare TRI & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRI | MDLN |
|---|---|---|
| Founded | 1851 | 1966 |
| Country | Canada | United States |
| Employees | N/A | 45000 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6B | 37.4B |
| IPO Year | 2002 | N/A |
| Metric | TRI | MDLN |
|---|---|---|
| Price | $89.53 | $40.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $154.58 | $50.48 |
| AVG Volume (30 Days) | 1.8M | ★ 9.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.90 | $10.88 |
| Revenue Next Year | $7.89 | $7.69 |
| P/E Ratio | ★ $25.72 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $76.28 | $32.82 |
| 52 Week High | $218.40 | $50.88 |
| Indicator | TRI | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 58.97 | 57.44 |
| Support Level | $87.72 | $38.50 |
| Resistance Level | $93.19 | $46.29 |
| Average True Range (ATR) | 3.22 | 1.51 |
| MACD | 1.12 | 0.39 |
| Stochastic Oscillator | 78.92 | 69.48 |
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.